Should I Buy YCBD? YCBD 2026 Analysis

Should You Buy cbdMD Inc (YCBD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.770

1 Day change

2.25%

52 Week Range

5.490

Analysis Updated At

2026/01/26

Based on the data provided, cbdMD Inc (YCBD) does not present a strong buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to justify an immediate purchase. It is best to hold off on investing in this stock for now.

Technical Analysis

The technical indicators show a neutral to bearish sentiment. The MACD is below 0 and negatively contracting, indicating weak momentum. The RSI is at 31.391, close to oversold but still in the neutral zone. Moving averages are converging, suggesting indecision in price direction. The pre-market price is $0.8308, down 2.13%, and is nearing the key support level at $0.819.

Options Data

Positive Catalysts

The gross margin increased by 12.07% YoY in Q4 2025, showing some operational improvement.

Neutral/Negative Catalysts

Net income dropped by 41.14% YoY, and EPS declined significantly by 94.33% YoY, indicating poor profitability. There is no recent news or significant insider or hedge fund activity to act as a catalyst. The stock has a small market cap of $8.91M, which may limit its appeal to institutional investors.

Financial Performance

In Q4 2025, revenue increased by 3.61% YoY to $4,720,770, but net income dropped to -$679,968, down 41.14% YoY. EPS declined significantly to -$0.08, down 94.33% YoY. Gross margin improved to 53.28%, up 12.07% YoY, but overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for YCBD.

1 Analyst Rating

Wall Street analysts forecast YCBD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for YCBD is 2 USD with a low forecast of 2 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.754

Low

Averages

High

Current: 0.754

Low

Averages

High

Maxim

Buy

downgrade

$3 -> $2

AI Analysis

2025-08-20

Reason

Maxim

Price Target

$3 -> $2

AI Analysis

2025-08-20

downgrade

Buy

Reason

Maxim lowered the firm's price target on cbdMD to $2 from $3 and keeps a Buy rating on the shares. The firm cites the company's Q3 loss coming in wider than expected amid softness in demand and regulatory uncertainties, the analyst tells investors in a research note. Maxim adds that while the company has partnered with industry advocacy groups to engage legislators and prioritize compliance with product quality and labeling requirements, it expects regulatory headwinds to persist, limiting growth through 2026.

Maxim

Buy

downgrade

$16 -> $3

2025-05-22

Reason

Maxim

Price Target

$16 -> $3

2025-05-22

downgrade

Buy

Reason

YCBD Should I Buy

YCBD Should I Buy

Should You Buy cbdMD Inc (YCBD) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch